A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophyKathryn R. Wagner, Jerry R. Mendell, Volker Straub et al.|Annals of Neurology|2008Cited by 466
Myasthenia GravisKlaus V. Toyka, Ing Kao, Daniel B. Drachman et al.|New England Journal of Medicine|1977Cited by 435
Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohortKevin M. Flanigan, Robert B. Weiss, Diane M. Dunn et al.|Human Mutation|2009Cited by 314
Long‐term benefit from prednisone therapy in Duchenne muscular dystrophyGerald M. Fenichel, Bradley Wilson, J. Florence et al.|Neurology|1991Cited by 266
<i><scp>LTBP4</scp></i> genotype predicts age of ambulatory loss in duchenne muscular dystrophyKevin M. Flanigan, Robert B. Weiss, Ermelinda Ceco et al.|Annals of Neurology|2012Cited by 242